|Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma|
BJ Poiesz, FW Ruscetti, AF Gazdar, PA Bunn, JD Minna, RC Gallo
Proceedings of the National Academy of Sciences 77 (12), 7415-7419, 1980
|Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing|
J Carmichael, WG DeGraff, AF Gazdar, JD Minna, JB Mitchell
Cancer research 47 (4), 936-942, 1987
|Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers|
H Shigematsu, L Lin, T Takahashi, M Nomura, M Suzuki, II Wistuba, ...
Journal of the National Cancer Institute 97 (5), 339-346, 2005
|Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs|
MG Kris, BE Johnson, LD Berry, DJ Kwiatkowski, AJ Iafrate, II Wistuba, ...
Jama 311 (19), 1998-2006, 2014
|Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer|
F Cuttitta, DN Carney, J Mulshine, TW Moody, J Fedorko, A Fischler, ...
Nature 316 (6031), 823-826, 1985
|p53: a frequent target for genetic abnormalities in lung cancer|
T Takahashi, MM Nau, I Chiba, MJ Birrer, RK Rosenberg, M Vinocour, ...
Science 246 (4929), 491-494, 1989
|BRAF and RAS mutations in human lung cancer and melanoma|
MS Brose, P Volpe, M Feldman, M Kumar, I Rishi, R Gerrero, E Einhorn, ...
Cancer research 62 (23), 6997-7000, 2002
|A small-cell lung cancer genome with complex signatures of tobacco exposure|
ED Pleasance, PJ Stephens, S O’Meara, DJ McBride, A Meynert, D Jones, ...
Nature 463 (7278), 184-190, 2010
|The national lung screening trial: overview and study design|
National Lung Screening Trial Research Team
Radiology 258 (1), 243-253, 2011
|Characterizing the cancer genome in lung adenocarcinoma|
BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ...
Nature 450 (7171), 893-898, 2007
|Amplification and expression of the c-myc oncogene in human lung cancer cell lines|
CD Little, MM Nau, DN Carney, AF Gazdar, JD Minna
Nature 306 (5939), 194-196, 1983
|High-throughput oncogene mutation profiling in human cancer|
RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ...
Nature genetics 39 (3), 347-351, 2007
|Establishment and identification of small cell lung cancer cell lines having classic and variant features|
DN Carney, AF Gazdar, G Bepler, JG Guccion, PJ Marangos, TW Moody, ...
Cancer research 45 (6), 2913-2923, 1985
|Abnormalities in structure and expression of the human retinoblastoma gene in SCLC|
JW Harbour, SL Lai, J Whang-Peng, AF Gazdar, JD Minna, FJ Kaye
Science 241 (4863), 353-357, 1988
|Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression|
DG Burbee, E Forgacs, S Zöchbauer-Müller, L Shivakumar, K Fong, ...
Journal of the National Cancer Institute 93 (9), 691-699, 2001
|Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer|
CM Rudin, S Durinck, EW Stawiski, JT Poirier, Z Modrusan, DS Shames, ...
Nature genetics 44 (10), 1111-1116, 2012
|SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas|
AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ...
Nature genetics 41 (11), 1238-1242, 2009
|An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor …|
LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ...
Clinical cancer research 19 (1), 279-290, 2013
|Cancer of the lung|
Cancer. Principles and practice of oncology 3, 591-705, 1989
|Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery|
J Kao, K Salari, M Bocanegra, YL Choi, L Girard, J Gandhi, KA Kwei, ...
PloS one 4 (7), e6146, 2009